References: Chapter 13
1.
Livingston, G., et al., Dementia Prevention, Intervention, and Care: 2024 Report of the Lancet standing Commission. The Lancet, 2024. 404(10452): pp. 572–628.
Senff, J., et al., Modifiable Risk Factors for Stroke, Dementia and Late-Life Depression: A Systematic Review and DALY-Weighted Risk Factors for Composite Outcome. Journal of Neurology, Neurosurgery & Psychiatry, 2025. 96(6): pp. 515–
27.
2.
Ruiter-Lopez, L., et al., Roles of Oxidative Stress and Autophagy in Alcohol-Mediated Brain Damage. Antioxidants, 2025. 14(3).
Ebrahim, I.O., et al., Alcohol and Sleep I: Effects on Normal Sleep. Alcoholism, Clinical and Experimental Research, 2013. 37(4): pp. 539–49.
3.
Biddinger, K.J., et al., Association of Habitual Alcohol Intake with Risk of Cardiovascular Disease. JAMA Network Open, 2022. 5(3): pp. e223849–e223849.
Wiegmann, C., et al., Alcohol and Dementia—What Is the Link? A Systematic Review. Neuropsychiatric Disease and Treatment, 2020. 16: pp. 87–99.
Wood, A.M., et al., Risk Thresholds for Alcohol Consumption: Combined Analysis of Individual-Participant Data for 599 912 Current Drinkers in 83 Prospective Studies. The Lancet, 2018. 391(10129): pp. 1513–23.
4.
Domínguez-López, I., et al., Urinary Tartaric Acid as a Biomarker of Wine Consumption and Cardiovascular Risk: The PREDIMED Trial. European Heart Journal, 2025. 46(2): pp. 161–72.
5.
Calabrese, E.J. and L.A. Baldwin, Ethanol and Hormesis. Critical Reviews in Toxicology, 2003. 33(3-4): pp. 407–24.
6.
Stockwell, T., et al., Why Do Only Some Cohort Studies Find Health Benefits from Low-Volume Alcohol Use? A Systematic Review and Meta-Analysis of Study Characteristics That May Bias Mortality Risk Estimates. Journal of Studies on Alcohol and Drugs, 2024. 85(4): pp. 441–52.
7.
Zhao, J., et al., Association Between Daily Alcohol Intake and Risk of All-Cause Mortality: A Systematic Review and Meta-Analyses. JAMA Network Open, 2023. 6(3): pp. e236185–e236185.
8.
Wood, A.M., et al., Risk Thresholds for Alcohol Consumption: Combined Analysis of Individual-Participant Data for 599,912 Current Drinkers in 83 Prospective Studies. The Lancet, 2018. 391(10129): pp. 1513–23.
Topiwala, A., et al., Alcohol Consumption and MRI Markers of Brain Structure and Function: Cohort Study of 25,378 UK Biobank Participants. NeuroImage: Clinical, 2022. 35: 103066.
9.
Xu, W., et al., Alcohol Consumption and Dementia Risk: A Dose–Response Meta-Analysis of Prospective Studies. European Journal of Epidemiology, 2017. 32(1): pp. 31–42.
10.
Brennan, S.E., et al., Long-Term Effects of Alcohol Consumption on Cognitive Function: A Systematic Review and Dose-Response Analysis of Evidence Published Between 2007 and 2018. Systematic Reviews, 2020. 9(1): 33.
Anstey, K.J., H.A. Mack, and N. Cherbuin, Alcohol Consumption as a Risk Factor for Dementia and Cognitive Decline: Meta-Analysis of Prospective Studies. The American Journal of Geriatric Psychiatry, 2009. 17(7): pp. 542–55.
11.
Daviet, R., et al., Associations Between Alcohol Consumption and Gray and White Matter Volumes in the UK Biobank. Nature Communications, 2022. 13(1): 1175.
Topiwala, A., et al., Alcohol Consumption and MRI Markers of Brain Structure and Function: Cohort Study of 25,378 UK Biobank Participants. NeuroImage: Clinical, 2022. 35: 103066.
Topiwala, A., et al., Alcohol use and risk of dementia in diverse populations: evidence from cohort, case–control and Mendelian randomisation approaches. BMJ Evidence-Based Medicine, 2026 Jan 21;31(1):13-22.
12.
How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General, 2010, National Library of Medicine. Available↗
Meysami, S., et al., Smoking Predicts Brain Atrophy in 10,134 Healthy Individuals and is Potentially Influenced by Body Mass Index. NPJ Dementia. 2025;1(1):17.
Oh, H.S., et al., Plasma Proteomics Links Brain and Immune System Aging with Healthspan and Longevity. Nature Medicine. 2025 Aug;31(8):2703-2711.
13.
Zhong, G., et al., Smoking Is Associated with an Increased Risk of Dementia: A Meta-Analysis of Prospective Cohort Studies with Investigation of Potential Effect Modifiers. PLoS One, 2015. 10(3): e0118333.
14.
CDC, Benefits of Quitting Smoking. 2024. Available↗
15.
Heishman, S.J., B.A. Kleykamp, and E.G. Singleton, Meta-Analysis of the Acute Effects of Nicotine and Smoking on Human Performance. Psychopharmacology, 2010. 210(4): pp. 453–69.
16.
Benowitz, N.L., Nicotine Addiction. The New England Journal of Medicine, 2010. 362(24): pp. 2295–303.
17.
Banks, E., et al., Electronic Cigarettes and Health Outcomes: Umbrella and Systematic Review of the Global Evidence. Medical Journal of Australia, 2023. 218(6): pp. 267–75.
López-Ojeda, W. and R.A. Hurley, Vaping and the Brain: Effects of Electronic Cigarettes and E-Liquid Substances. The Journal of Neuropsychiatry and Clinical Neurosciences, 2024. 36(1): pp. A5–5.
Salazar, M.R., et al., Elevated Toxic Element Emissions from Popular Disposable E‑Cigarettes: Sources, Life Cycle, and Health Risks. ACS Central Science. 2025 Jun 25;11(8):1345-1354.
18.
Thompson, D. Vaping Is Harming College Students’ Brains, Study Shows. American Neurological Association, September 15, 2024. Available↗
Novak, M.L. and G.Y. Wang, The Effect of E-Cigarettes on Cognitive Function: A Scoping Review. Psychopharmacology, 2024. 241(7): pp. 1287–97.
19.
von Cederwald, B.F., et al., Association of Cardiovascular Risk Trajectory with Cognitive Decline and Incident Dementia. Neurology, 2022. 98(20): pp. e2013–e2022
Song, R., et al., Associations Between Cardiovascular Risk, Structural Brain Changes, and Cognitive Decline. Journal of the American College of Cardiology, 2020. 75(20): pp. 2525–34.
Cherbuin, N., et al., Optimal Blood Pressure Keeps Our Brains Younger. Frontiers in Aging Neuroscience. 2021 Oct 5;13:694982.
Belessiotis-Richards, C.,. Systemic Medications and Dementia Risk: a Systematic Umbrella Review. Molecular Psychiatry. 2025 Jul 24.
Nordestgaard, L.T., et al., Cholesterol-lowering drug targets reduce risk of dementia: Mendelian randomization and meta-analyses of 1 million individuals. Alzheimer’s and Dementia. 2025 Oct;21(10):e70638.
20.
Types of Dementia. Alzheimer’s Disease International. Available↗
21.
About Dementia. CDC, August 17, 2024. Available↗
22.
Kapasi, A. and J.A. Schneider, Vascular Contributions to Cognitive Impairment, Clinical Alzheimer’s Disease, and Dementia in Older Persons. Biochimica et Biophysica Acta—Molecular Basis of Disease, 2016. 1862(5): pp. 878–86.
Scheffer, S., et al., Vascular Hypothesis of Alzheimer Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 2021. 41(4): pp. 1265–83.
Nedergaard, M. and S.A. Goldman, Glymphatic Failure as a Final Common Pathway to Dementia. Science, 2020. 370(6512): pp. 50–56.
23.
Dhana, A., et al., Cardiovascular Health and Biomarkers of Neurodegenerative Disease in Older Adults. JAMA Network Open, 2025. 8(3): pp. e250527–e250527.
Li, J., et al., The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease, 2024. 97(4): pp. 1589–620.
24.
Neher, C.M., et al., Perfusion–Mechanics Coupling of the Hippocampus. Interface Focus, 2025. 15(1): 20240051.
25.
Lee, J., et al., Association Between Metabolic Syndrome and Young-Onset Dementia. Neurology, 2025. 104(10):
e213599.
26.
Hendriks, S., et al., Risk Factors for Young-Onset Dementia in the UK Biobank. JAMA Neurology, 2024. 81(2): pp. 134–42.
27.
Yao, H., et al., Comparative Effectiveness of GLP-1 Receptor Agonists on Glycaemic Control, Body Weight, and Lipid Profile for Type 2 Diabetes: Systematic Review and Network Meta-Analysis. The BMJ, 2024. 384: e076410.
Hendriks et al., Risk Factors for Young-Onset Dementia in the UK Biobank. JAMA Neurology, 2024. 81(2): pp. 134–42
28.
Memel, Z., et al., Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. Current Nutrition Reports, 2025. 14(1): 63.
Tinsley, G.M. and S.B. Heymsfield, Fundamental Body Composition Principles Provide Context for Fat-Free and Skeletal Muscle Loss with GLP-1 RA Treatments. Journal of the Endocrine Society, 2024. 8(11): bvae164.
Mozaffarian, D., et al., Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity, 2025 Aug;33(8):1475-1503.
29.
Hughes, D., et al., Association of Blood Pressure Lowering with Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. JAMA, 2020. 323(19): pp. 1934–44.
Reboussin, D.M., et al., Long-Term Effect of Intensive vs Standard Blood Pressure Control on Mild Cognitive Impairment and Probable Dementia in SPRINT. Neurology. 2025 Feb 11;104(3):e213334.
30.
Peters, R., et al., Blood Pressure Lowering and Prevention of Dementia: An Individual Patient Data Meta-Analysis. European Heart Journal, 2022. 43(48): pp. 4980–90.
31.
Chan, R.J., et al., Blood Pressure Control Should Focus on More Potassium: Controversies in Hypertension. Hypertension, 2024. 81(3): pp. 501–09.
Ma, Y., et al., 24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk. The New England Journal of Medicine, 2022. 386(3): pp. 252–63.
Stadt, M., and Layton, A.T., Modulation of Blood Pressure by Dietary Potassium and Sodium: Sex Differences and Modeling Analysis. American Journal of Physiol Renal Physiology. 2025 Mar 1;328(3):F406-F417.
32.
Huang, L., et al., Effect of Dose and Duration of Reduction in Dietary Sodium on Blood Pressure Levels: Systematic Review and Meta-Analysis of Randomised Trials. The BMJ, 2020. 368: m315.
Filippini, T., et al., Blood Pressure Effects of Sodium Reduction. Circulation, 2021. 143(16): pp. 1542–67.
He, F.J., J. Li, and G.A. Macgregor, Effect of Longer Term Modest Salt Reduction on Blood Pressure: Cochrane Systematic Review and Meta-Analysis of Randomised Trials. The BMJ, 2013. 346: f1325.
33.
Filippini, T., et al., Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 2020. 9(12): e015719.
Aliasgharzadeh, S., et al., Effect of Salt Reduction Interventions in Lowering Blood Pressure: A Comprehensive Systematic Review and Meta-Analysis of Controlled Clinical Trials. PLoS One, 2022. 17(12): e0277929.
34.
Bhat, S., et al., A Systematic Review of the Sources of Dietary Salt Around the World. Advances in Nutrition, 2020. 11(3): pp. 677–86.
35.
Wong, T.H., A. Sim, and S.F. Burns, The Effects of Nitrate Ingestion on High-Intensity Endurance Time-Trial Performance: A Systematic Review and Meta-Analysis. Journal of Exercise Science and Fitness, 2022 Oct;20(4):305-316.
Gao, C., et al., The Effects of Dietary Nitrate Supplementation on Endurance Exercise Performance and Cardiorespiratory Measures in Healthy Adults: A Systematic Review and Meta-Analysis. Journal of the International Society of Sports Nutrition 18, 55 (2021).
Webb, A.J., et al., Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate Via Bioconversion to Nitrite. Hypertension. 2008 51(3):784-90.
Sweazea, K.L., et al., Nitrate-Rich Fruit and Vegetable Supplement Reduces Blood Pressure in Normotensive Healthy Young Males Without Significantly Altering Flow-Mediated Vasodilation: A Randomized, Double-Blinded, Controlled Trial. Journal of Nutrition and Metabolism, 2018 Sep 16;2018:1729653.
Norouzzadeh, M., et al., Plasma Nitrate, Dietary Nitrate, Blood Pressure, and Vascular Health Biomarkers: A GRADE-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Nutrition Journal, 2025 Mar 24;24(1):47. doi: 10.1186/s12937-025-01114-8.
Kapil, V., et al., Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radical Biology and Medicine. 2013 Feb;55:93-100. doi: 10.1016/j.freeradbiomed.2012.11.013.
36.
Baik, M., et al., Differential Association Between Apolipoprotein B and LDL Cholesterol and Cerebral Atherosclerosis According to Pre-Stroke Statin Use. Atherosclerosis, 2023. 371: pp. 14–20.
Sniderman, A.D., et al., Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology, 2019. 4(12): pp. 1287–95.
Nordestgaard, L.T., et al., Cholesterol-lowering drug targets reduce risk of dementia: Mendelian randomization and meta-analyses of 1 million individuals. Alzheimer’s and Dementia. 2025 Oct;21(10):e70638.
37.
Bjornstad, P., and R.H. Eckel, Pathogenesis of Lipid Disorders in Insulin Resistance: A Brief Review. Current Diabetes Reports, 2018. 18(12): 127.
38.
Smart, N.A., et al., The Effect of Exercise Training on Blood Lipids: A Systematic Review and Meta-Analysis. Sports Medicine, 2025. 55(1): pp. 67–78.
Papadaki, A., E. Nolen-Doerr, and C.S. Mantzoros, The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults. Nutrients, 2020. 12(11).
Schoeneck, M. and D. Iggman, The Effects of Foods on LDL Cholesterol Levels: A Systematic Review of the Accumulated Evidence from Systematic Reviews and Meta-Analyses of Randomized Controlled Trials. Nutrition, Metabolism & Cardiovascular Disease, 2021. 31(5): pp. 1325–38.
39.
Schwingshackl, L., et al., Effects of Oils and Solid Fats on Blood Lipids: A Systematic Review and Network Meta-Analysis. Journal of Lipid Research, 2018. 59(9): pp. 1771–82.
40.
Schwingshackl, L. and G. Hoffmann, Monounsaturated Fatty Acids, Olive Oil and Health Status: A Systematic Review and Meta-Analysis of Cohort Studies. Lipids in Health and Disease, 2014. 13(1): 154.
Li, J., et al., Dietary Intake and Biomarkers of Linoleic Acid and Mortality: Systematic Review and Meta-Analysis of Prospective Cohort Studies. The American Journal of Clinical Nutrition, 2020. 112(1): pp. 150–67.
Sadeghi, R., et al., Dietary and Circulating Omega-6 Fatty Acids and Their Impact on Cardiovascular Disease, Cancer Risk, and Mortality: A Global Meta-Analysis of 150 Cohorts and Meta-Regression. Journal of Translational Medicine, 2025. 23(1): 314.
41.
Ghavami, A., et al., Soluble Fiber Supplementation and Serum Lipid Profile: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Advances in Nutrition, 2023. 14(3): pp. 465–74.
Fu, L., et al., Associations Between Dietary Fiber Intake and Cardiovascular Risk Factors: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. Frontiers in Nutrition, 2022. 9: 972399.
Brum, J., et al., Meta-Analysis of Usefulness of Psyllium Fiber as Adjuvant Antilipid Therapy to Enhance Cholesterol Lowering Efficacy of Statins. American Journal of Cardiology. 2018 Oct 1;122(7):1169-1174.
42.
Reddin, C., et al., Association of lipid-lowering therapy with dementia and cognitive outcomes: a systematic review and meta-analysis. Age and Ageing. 2025 Aug 1;54(8):afaf219.
43.
Filho, F.L.W., et al., Statin Use and Dementia Risk: A Systematic Review and Updated Meta-Analysis. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2025. 11(1): e70039.
44.
Ridker, P.M., et al., Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. The New England Journal of Medicine, 2008. 359(21): pp. 2195–207.
Heneka, M.T., et al., Neuroinflammation in Alzheimer disease. Nature Reviews Immunology, 2025 25, 321–352.
45.
Goldstein, L.B., et al., Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 2023. 43(10): pp. e404–e442.
46.
Joseph, J., et al., Pragmatic Evaluation of Events and Benefits of Lipid Lowering in Older Adults (PREVENTABLE): Trial Design and Rationale. Journal of the American Geriatrics Society, 2023. 71(6): pp. 1701–13.
Zoungas, S., et al., Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older People. Journal of the American Heart Association, 2024. 13(22): e036357.
47.
Gong, J., et al., Serum Lipid Traits and the Risk of Dementia: A Cohort Study of 254,575 Women and 214,891 Men in the UK Biobank. EClinicalMedicine, 2022. 54: 101695.
48.
Soffer, D.E., et al., Role of Apolipoprotein B in the Clinical Management of Cardiovascular Risk in Adults: An Expert Clinical Consensus from the National Lipid Association. Journal of Clinical Lipidology, 2024. 18(5): pp. e647–e663.
Martin, L., et al., Mendelian Randomization Reveals Apolipoprotein B Shortens Healthspan and Possibly Increases Risk for Alzheimer’s Disease. Communications Biology, 2024. 7(1): 230.
Gong et al., Serum Lipid Traits and the Risk of Dementia: A Cohort Study of 254,575 Women and 214,891 Men in the UK Biobank. EClinicalMedicine, 2022. 54: 101695.
49.
de Heus, R.A.A., et al., Association Between Blood Pressure Variability with Dementia and Cognitive Impairment: A Systematic Review and Meta-Analysis. Hypertension, 2021. 78(5): pp. 1478–89.
50.
Ott, B.R., et al., Do Statins Impair Cognition? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of General Internal Medicine. 2015 Mar;30(3):348-58.
Jamshidnejad-Tosaramandani, T., et al., Statins and Cognition: Modifying Factors and Possible Underlying Mechanisms. Frontiers in Aging Neuroscience. 2022 Aug 15;14:968039.
Kazibwe, R., et al., Do Statins Affect Cognitive Health? A Narrative Review and Critical Analysis of the Evidence. Current Atherosclerosis Reports, 2024, 9;27(1):2.
Tan, B., et al., Evidence and mechanisms for statin-induced cognitive decline. Expert Review of Clinical Pharmacology, 2019. 12(5), 397–406.
Cholesterol Treatment Trialists' (CTT) Collaboration. Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials. Lancet. 2026 Feb 14;407(10529):689-703.
51.
Qu, H., et al., Effects of Coenzyme Q10 on Statin‐Induced Myopathy: An Updated Meta‐Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 2018. 7(19): e009835.
Mehrabani, S., et al., Effect of Coenzyme Q10 Supplementation on Fatigue: A Systematic Review of Interventional Studies. Complementary Therapies in Medicine, 2019. 43: pp. 181–87.
52.
Tang, C., et al., Association of Metformin Use with Risk of Dementia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diabetes, Obesity and Metabolism, 2025. 27(4): pp. 1992–2001.
53.
Metformin and Reduced Vitamin B12 Levels: New Advice for Monitoring Patients at Risk. Gov.UK, June 20, 2022. Available↗
54.
Nehra, A.K., et al., Proton Pump Inhibitors: Review of Emerging Concerns. Mayo Clinic Proceedings, 2018. 93(2): pp. 240–46.
55.
Northuis, C.A., et al., Cumulative Use of Proton Pump Inhibitors and Risk of Dementia. Neurology, 2023. 101(18): pp. e1771–e1778.
Pourhadi, N., et al., Proton Pump Inhibitors and Dementia: A Nationwide Population-Based Study. Alzheimer’s & Dementia, 2024. 20(2): pp. 837–45.
56.
Mehta, R.S., et al., Association of Proton Pump Inhibitor Use with Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study. Gastroenterology, 2023. 165(3): pp. 564–72.e1.
57.
American Geriatrics Society Beers Criteria Update Expert Panel, American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society, 2023. 71(7): pp. 2052–81.
58.
Patwardhan, V., et al., Differences Across the Lifespan Between Females and Males in the Top 20 Causes of Disease Burden Globally: A Systematic Analysis of the Global Burden of Disease Study 2021. The Lancet Public Health, 2024. 9(5): pp. e282–e294.
59.
GBD 2016 Neurology Collaborators, Global, Regional, and National Burden of Neurological Disorders, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Neurology, 2019. 18(5): pp. 459–80.
Gao, P., et al., Global, Regional, and National Trends in Incidence of Depression Among Women, 1990–2019: An Analysis of the Global Burden of Disease Study. Psychiatry Research, 2024. 331: 115668.
60.
Beery, A.K. and I. Zucker, Sex Bias in Neuroscience and Biomedical Research. Neuroscience and Biobehavioral Reviews, 2011. 35(3): pp. 565–72.
61.
Wood, T.R., and Nance E.A., Disease-Directed Engineering for Physiology-Driven Treatment Interventions in Neurological Disorders. APL Bioengineering, 2019. 3(4): 040901.
62.
Bourzac, K., Why Women Experience Alzheimer’s Disease Differently from Men. Nature, 2025. 640(8059): pp. S14–S17.
Mosconi, L., et al., Neurophysiological Correlates of Subjective Cognitive Decline in Perimenopausal and Postmenopausal Midlife Women at Risk for Alzheimer’s Disease. Menopause, 2025. 32(5): pp. 433–42.
Science Advances’ special issue on women’s health. Science Advances, 2025. 11(10).
63.
McCarthy, M.M., A New View of Sexual Differentiation of Mammalian Brain. Journal of Comparative Physiology, A: Neuroethology, Sensory, Neural, and Behavioral Physiology, 2020. 206(3): pp. 369–78.
McCarthy, M.M., et al., Sex Differences in the Brain: The Not So Inconvenient Truth. The Journal of Neuroscience, 2012. 32(7): pp. 2241–47.
Pavlinek, A., et al., Using Organoids to Model Sex Differences in the Human Brain. Biological Psychiatry Global Open Science, 2024. 4(5): 100343.
McCarthy, M.M., et al., Surprising Origins of Sex Differences in the Brain. Horm Behav, 2015. 76: pp. 3–10.
Demarest, T.G. and M.M. McCarthy, Sex Differences in Mitochondrial (Dys)Function: Implications for Neuroprotection. Journal of Bioenergetics and Biomembranes, 2015. 47(1-2): pp. 173–88.
Martínez de Toda, I., et al., Sex Differences in Markers of Oxidation and Inflammation. Implications for Ageing. Mechanisms of Ageing and Development, 2023. 211: 111797.
64.
Smith, S.M., et al., An Expanded Set of Genome-Wide Association Studies of Brain Imaging Phenotypes in UK Biobank. Nature Neuroscience, 2021. 24(5): pp. 737–45.
Belloy, M.E., et al., Role of the X Chromosome in Alzheimer Disease Genetics. JAMA Neurology, 2024. 81(10): pp. 1032–42.
65.
Scharfman, H.E. and N.J. MacLusky, Estrogen and Brain-Derived Neurotrophic Factor (BDNF) in Hippocampus: Complexity of Steroid Hormone-Growth Factor Interactions in the Adult CNS. Frontiers in Neuroendocrinology, 2006. 27(4): pp. 415–35.
Finkelstein, J.S., et al., Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men. The New England Journal of Medicine, 2013. 369(11): pp. 1011–22.
Kodete, C.S., et al., Hormonal Influences on Skeletal Muscle Function in Women across Life Stages: A Systematic Review. Muscles, 2024. 3(3): pp. 271–86.
Bethea, C.L., et al., Diverse Actions of Ovarian Steroids in the Serotonin Neural System. Frontiers in Neuroendocrinology, 2002. 23(1): pp. 41–100.
Rettberg, J.R., J. Yao, and R.D. Brinton, Estrogen: A Master Regulator of Bioenergetic Systems in the Brain and Body. Frontiers in Neuroendocrinology, 2014. 35(1): pp. 8–30.
66.
Brinton, R.D., et al., Perimenopause as a Neurological Transition State. Nature Reviews, Endocrinology, 2015. 11(7): pp. 393–405.
Thurston, R.C., et al., Menopause as a Biological and Psychological Transition. Nature Reviews Psychology, 2025 4, 530–543.
Soares, C.N., et al., The burden of sleep disturbances on quality of life and mental well-being in nearly 50,000 perimenopausal and postmenopausal women with and without concurrent vasomotor symptoms from the United States and Europe. Menopause. 2026 Mar 1;33(3):261-269.
67.
Maki, P.M. and M.T. Weber, A Research Primer for Studies of Cognitive Changes Across the Menopause Transition. Climacteric, 2021. 24(4): pp. 382–88.
Bangle, A., et al., Cognitive functioning in perimenopause: An updated systematic review and meta-analysis. Psychology and Aging, 2025 Oct 9.
68.
Mosconi, L., et al., Perimenopause and Emergence of an Alzheimer’s Bioenergetic Phenotype in Brain and Periphery. PLoS One, 2017. 12(10): e0185926.
69.
Mosconi, L., et al., in Vivo Brain Estrogen Receptor Density by Neuroendocrine Aging and Relationships with Cognition and Symptomatology. Scientific Reports, 2024. 14(1): 12680.
70.
Shumaker, S.A., et al., Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women’s Health Initiative Memory Study: A Randomized Controlled Trial. JAMA, 2003. 289(20): pp. 2651–62.
Rapp, S.R., et al., Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women: The Women’s Health Initiative Memory Study: A Randomized Controlled Trial. JAMA, 2003. 289(20): pp. 2663–72.
71.
Maki, P.M., et al., Hormone Therapy in Menopausal Women with Cognitive Complaints: A Randomized, Double-Blind Trial. Neurology, 2007. 69(13): pp. 1322–30.
Gleason, C.E., et al., Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS–Cognitive and Affective Study. PLOS Medicine, 2015. 12(6): e1001833.
Espeland, M.A., et al., Long-Term Effects on Cognitive Function of Postmenopausal Hormone Therapy Prescribed to Women Aged 50 to 55 Years. JAMA Intern Med, 2013. 173(15): pp. 1429–36.
Henderson, V.W., et al., Cognitive Effects of Estradiol After Menopause: A Randomized Trial of the Timing Hypothesis. Neurology. 2016 Aug 16;87(7):699-708.
Gleason, C.E., et al., Long-Term Cognitive Effects of Menopausal Hormone Therapy: Findings From the KEEPS Continuation Study. PLoS Med. 2024 Nov 21;21(11):e1004435.
Faubion, L.L., et al., Long-Term Effects of 4 Years of Menopausal Hormone Therapy on White Matter Integrity. Menopause. 2025 Jul 22;32(9):818–28.
Melville, M., et al., Menopause hormone therapy and risk of mild cognitive impairment or dementia: a systematic review and meta-analysis. Lancet Healthy Longevity. 2025 Dec;6(12):100803.
72.
The 2022 Hormone Therapy Position Statement of the North American Menopause Society. Menopause, 2022. 29(7): pp. 767–94.
Gravelsins, L.L., and Galea, L.A.M., One Size Does Not Fit All: How Type of Menopause and Hormone Therapy Matters for Brain Health. British Journal of Psychiatry. 2025 Jun;226(6):369-382.
Glynne, S., et al., Transdermal Oestradiol and Testosterone Therapy for Menopausal Depression and Mood Symptoms: Retrospective Cohort Study. British Journal of Psychiatry. 2025 Jun 16:1-10.
73.
Andy, C., et al., Systematic Review and Meta-Analysis of the Effects of Menopause Hormone Therapy on Cognition. Frontiers in Endocrinology, 2024. 15: 1350318.
74.
The 2022 Hormone Therapy Position Statement of the North American Menopause Society. Menopause, 2022. 29(7): pp. 767–94.
Gravelsins, L.L., and Galea, L.A.M., One Size Does Not Fit All: How Type of Menopause and Hormone Therapy Matters for Brain Health. British Journal of Psychiatry. 2025 Jun;226(6):369-382.
Glynne, S., et al., Transdermal Oestradiol and Testosterone Therapy for Menopausal Depression and Mood Symptoms: Retrospective Cohort Study. British Journal of Psychiatry. 2025 Jun 16:1-10.
75.
Kim, Y.J., et al., Association Between Menopausal Hormone Therapy and Risk of Neurodegenerative Diseases: Implications for Precision Hormone Therapy. Alzheimer’s & Dementia, 2021. 7(1): e12174.
Nerattini, M., et al., Systematic Review and Meta-Analysis of the Effects of Menopause Hormone Therapy on Risk of Alzheimer’s Disease and Dementia. Frontiers in Aging Neuroscience, 2023. 15: 1260427.
76.
Thurston, R.C., et al., Menopausal Hot Flashes and the Default Mode Network. Fertil Steril, 2015. 103(6): pp. 1572–78.e1.
77.
Maki, P.M., et al., Stellate Ganglion Blockade and Verbal Memory in Midlife Women: Evidence from a Randomized Trial. Maturitas, 2016. 92: pp. 123–29.
78.
Faubion, S.S., et al., The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022. 29(7):p 767-794.
79.
Kazlauskaite, R., et al., Is Midlife Metabolic Syndrome Associated with Cognitive Function Change? the Study of Women’s Health Across the Nation. The Journal of Endocrinology & Metabolism, 2020. 105(4): pp. e1093–105.
80.
Gold, E.B., et al., Relation of Demographic and Lifestyle Factors to Symptoms in a Multi-Racial/Ethnic Population of Women 40-55 Years of Age. Am Journal of Epidemiology, 2000. 152(5): pp. 463–73.
Blümel, J.E., et al., Sedentary Lifestyle in Middle-Aged Women Is Associated with Severe Menopausal Symptoms and Obesity. Menopause, 2016. 23(5): pp. 488–93.
Berin, E., et al., Resistance training for hot flushes in postmenopausal women: A randomised controlled trial. Maturitas, 2019. 126:55-60.
Liu, T., et al., Effects of Exercise on Vasomotor Symptoms in Menopausal Women: A Systematic Review and Meta-Analysis. Climacteric, 2022. 25(6): pp. 552–61.
Yue, H., et al., Effects of Physical Activity on Depressive and Anxiety Symptoms of Women in the Menopausal Transition and Menopause: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials. International Journal of Behavioral Nutrition and Physical Activity, 2025. 22(1): 13.
81.
Lam, C.M., et al., Behavioral Interventions for Improving Sleep Outcomes in Menopausal Women: A Systematic Review and Meta-Analysis. Menopause, 2022. 29(10): pp. 1210–21.
82.
Firquet, A., K. Wolf, and J. and Bitzer, Forty-to-Fifty-Five-Year-Old Women and Iron Deficiency: Clinical Considerations and Quality of Life. Gynecological Endocrinology, 2017. 33(7): pp. 503–09.
83.
Hong, C.H., et al., Anemia and risk of dementia in older adults: findings from the Health ABC study. Neurology, 2013. 6;81(6):528-33.
84.
Shah, R.C., et al., Hemoglobin Level in Older Persons and Incident Alzheimer Disease: Prospective Cohort Analysis. Neurology, 2011. 77(3): pp. 219–26.
85.
Greendale, G.A., et al., Effects of the Menopause Transition and Hormone Use on Cognitive Performance in Midlife Women. Neurology, 2009. 72(21): pp. 1850–57.
86.
Campbell, K.E., et al., The trajectory of negative mood and depressive symptoms over two decades. Maturitas, 2017.95:36-41.
87.
Hvas, L., Positive Aspects of Menopause: A Qualitative Study. Maturitas, 2001. 39(1): pp. 11–7.
88.
Horne, K., et al., Development of the Flexibility in Daily Life Scale to Measure Multidimensional Cognitive and Behavioural Flexibility in Health and Disease. British Journal of Clinical Psychology. 2025 Jun;64(2):315-329.
Gignac G.E., and Zajenkowski, M., Humans peak in midlife: A combined cognitive and personality trait perspective. Intelligence, 2025. 113:101961.
89.
Mukherjee, A. and S.R. Davis, Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions. Clinical Endocrinology, 2025.
Baik S.H., Baye F., and McDonald C.J., Use of Menopausal Hormone Therapy Beyond Age 65 Years and Its Effects on Women’s Health Outcomes by Types, Routes, and Doses. Menopause, 2024. 31(5): pp. 363–71.
90.
Höfer, P., R. Lanzenberger, and S. Kasper, Testosterone in the Brain: Neuroimaging Findings and the Potential Role for Neuropsychopharmacology. European Neuropsychopharmacology, 2013. 23(2): pp. 79–88.
Wang, X., et al., Lower Plasma Total Testosterone Levels Were Associated with Steeper Decline in Brain Glucose Metabolism in Non-demented Older Men. Frontiers in Aging Neuroscience, 2021. 13: 592845.
91.
Marriott, R.J., et al., Lower Serum Testosterone Concentrations Are Associated with a Higher Incidence of Dementia in Men: The UK Biobank Prospective Cohort Study. Alzheimer’s & Dementia, 2022. 18(10): pp. 1907–18.
Joshi, D., et al., Low Free Testosterone Levels Are Associated with Prevalence and Incidence of Depressive Symptoms in Older Men. Clinical Endocrinology, 2010. 72(2): pp. 232–40.
Shores, M.M., et al., Increased Incidence of Diagnosed Depressive Illness in Hypogonadal Older Men. Archives of General Psychiatry, 2004. 61(2): pp. 162–67.
92.
Yeap, B.B., et al., Sociodemographic, Lifestyle and Medical Influences on Serum Testosterone and Sex Hormone–Binding Globulin in Men from UK Biobank. Clinical Endocrinology, 2021. 94(2): pp. 290–302.
Crisóstomo, L., et al., Lifestyle, Metabolic Disorders and Male Hypogonadism—A One-Way Ticket? Molecular and Cellular Endocrinology, 2020. 516: 110945.
Su, L., et al., Effect of Partial and Total Sleep Deprivation on Serum Testosterone in Healthy Males: A Systematic Review and Meta-Analysis. Sleep Medicine, 2021. 88: pp. 267–73.
Tančić-Gajić, M., et al., Obstructive Sleep Apnea Is Associated with Low Testosterone Levels in Severely Obese Men. Frontiers in Endocrinology, 2021. 12: 622496.
La Vignera, S., et al., Short-Term Impact of Tirzepatide on Metabolic Hypogonadism and Body Composition in Patients with Obesity: a Controlled Pilot Study. Reproductive Biology and Endocrinology. 2025 Jul 2;23(1):92.
Preston, J.M., et al., Effect of Ultra-Processed Food Consumption on Male Reproductive and Metabolic Health. Cell Metababolism. 2025 Aug 22:S1550-4131(25)00360-2.
Lazarev, A., et al., Testosterone-Optimizing Strategies in Athletes. Sports Health. 2026 Feb 2:19417381251411933.
93.
Emmelot-Vonk, M.H., et al., Effect of Testosterone Supplementation on Functional Mobility, Cognition, and Other Parameters in Older Men: A Randomized Controlled Trial. JAMA, 2008. 299(1): pp. 39–52.
Zhang, Z., D. Kang, and H. Li, Testosterone and Cognitive Impairment or Dementia in Middle-Aged or Aging Males: Causation and Intervention, a Systematic Review and Meta-Analysis. Journal of Geriatric Psychiatry and Neurology, 2021. 34(5): pp. 405–17.
Buskbjerg, C.R., et al., Testosterone Supplementation and Cognitive Functioning in Men—A Systematic Review and Meta-Analysis. Journal of the Endocrine Society, 2019. 3(8): pp. 1465–84.
94.
Donatucci, C., et al., Long‐Term Treatment Patterns of Testosterone Replacement Medications. The Journal of Sexual Medicine, 2014. 11(8): pp. 2092–99.
Schoenfeld, M.J., et al., Medication Adherence and Treatment Patterns for Hypogonadal Patients Treated with Topical Testosterone Therapy: A Retrospective Medical Claims Analysis. The Journal of Sexual Medicine, 2013. 10(5): pp. 1401–409.
95.
Wahjoepramono, E.J., et al., The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men. CNS & Neurological Disorder Drug Targets, 2016. 15(3): pp. 337–43.
96.
Guo, C., et al., Efficacy and Safety of Testosterone Replacement Therapy in Men with Hypogonadism: A Meta-Analysis Study of Placebo-Controlled Trials. Experimental and Therapeutic Medicines, 2016. 11(3): pp. 853–63.
Elliott, J., et al., Testosterone Therapy in Hypogonadal Men: A Systematic Review and Network Meta-Analysis. The BMJ Open, 2017. 7(11): e015284.
97.
Bredesen, D.E., Reversal of Cognitive Decline: A Novel Therapeutic Program. Aging, 2014. 6(6): pp. 707–17.
98.
Galvan, V., et al., Reversal of Alzheimer’s-Like Pathology and Behavior in Human APP Transgenic Mice by Mutation of Asp664. Proceedings of the National Academy of Sciences of the U.S., 2006. 103(18): pp. 7130–35.
Bredesen, D.E., The End of Alzheimer’s: The First Program to Prevent and Reverse Cognitive Decline. 2017, Avery.
Bredesen, D.E., The Ageless Brain: How to Sharpen and Protect Your Mind for a Lifetime. 2025, Flatiron Books.
99.
Toups, K., et al., Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project. Journal of Alzheimer’s Disease, 2022. 88(4): pp. 1411–21.
Toups, K., et al., Precision Medicine Treatment of Alzheimer’s Disease: Successful Randomized Controlled Trial. Preprints 2025, 2025122694.
100.
James, B.D., et al., Cognitive Decline After Elective and Nonelective Hospitalizations in Older Adults. Neurology, 2019. 92(7): pp. e690–99.
101.
Soysal, P., et al., Inflammation and Frailty in the Elderly: A Systematic Review and Meta-Analysis. Ageing Research Reviews, 2016. 31: pp. 1–8.
102.
Allison, R., et al., Frailty: Evaluation and Management. American Family Physician, 2021. 103(4): 219–26.
103.
Copeland, E.N., et al., The Link Between Sarcopenic Obesity and Alzheimer’s Disease: A Brain-Derived Neurotrophic Factor Point of View. The Journal of Physiology, February 12, 2025.
Zhang, J., et al., Sarcopenic Obesity Is Part of Obesity Paradox in Dementia Development: Evidence from a Population-Based Cohort Study. BMC Medicine, 2024. 22(1): 133.
Someya, Y., et al., Sarcopenic Obesity Is Associated with Cognitive Impairment in Community-Dwelling Older Adults: The Bunkyo Health Study. Clinical Nutrition, 2022. 41(5): pp. 1046–51.
Wei, S., et al., Sarcopenic Obesity: Epidemiology, Pathophysiology, Cardiovascular Disease, Mortality, and Management. Frontiers in Endocrinology, 2023. 14: 1185221.
Ji, T., Y. Li, and L. Ma, Sarcopenic Obesity: An Emerging Public Health Problem. Aging and Disease, 2022. 13(2): pp. 379-88.
104.
Liu, Z. and C. Zhu, Causal Relationship Between Insulin Resistance and Sarcopenia. Diabetology & Metabolic Syndrome, 2023. 15(1): 46.
Merz, K.E. and D.C. Thurmond, Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake. Comprehensive Physiology, 2020. 10(3): pp. 785–809.
Zhang, M., et al., Muscle quality index is correlated with insulin resistance and type 2 diabetes mellitus: a cross-sectional population-based study. BMC Public Health. 2025 Feb 6;25(1):497.
105.
Zhang, J., et al., Comparative Efficacy of Exercise Interventions for Cognitive Health in Older Adults: A Network Meta-Analysis. Experimental Gerontology, 2025. 206: 112768.
106.
Pan, L., et al., Inflammation and Sarcopenia: A Focus on Circulating Inflammatory Cytokines. Experimental Gerontology, 2021. 154: 111544.
Bradburn, S., J. Sarginson, and C.A. Murgatroyd, Association of Peripheral Interleukin-6 with Global Cognitive Decline in Non-demented Adults: A Meta-Analysis of Prospective Studies. Frontiers in Aging Neuroscience, 2017. 9: 438.
Balter, L.J.T., et al., Inflammation Mediates Body Weight and Ageing Effects on Psychomotor Slowing. Scientific Reports, 2019. 9(1): 15727.
Klinedinst, B.S., et al., Aging-Related Changes in Fluid Intelligence, Muscle and Adipose Mass, and Sex-Specific Immunologic Mediation: A Longitudinal UK Biobank Study. Brain, Behavior, and Immunity, 2019. 82: pp. 396–405.
Ji, T., Y. Li, and L. Ma, Sarcopenic Obesity: An Emerging Public Health Problem. Aging and Disease, 2022. 13(2): pp. 379–88.
Wu, J., et al., Study on the comorbid mechanisms of sarcopenia and late-life depression. Behavioural Brain Research, 2025, 485, 1–25.
107.
DiSabato, D.J., N. Quan, and J.P. Godbout, Neuroinflammation: The Devil Is in the Details. Journal of Neurochemistry, 2016. 139(Suppl 2): pp. 136–53.
108.
Gruol, D.L., IL-6 regulation of Synaptic Function in the CNS. Neuropharmacology, 2015. 96(Pt A): pp. 42–54.
DiSabato, Quan, and Godbout, Neuroinflammation: The Devil Is in the Details. Journal of Neurochemistry, 2016. 139 Suppl 2(Suppl 2): pp. 136–53.
109.
Mottahedin, A., et al., Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders. Frontiers in Cellular Neuroscience, 2017. 11: 190.
Paolicelli, R.C., et al., Microglia States and Nomenclature: A Field at Its Crossroads. Neuron, 2022. 110(21): pp. 3458–83.
Zhang, W., et al., Role of Neuroinflammation in Neurodegeneration Development. Signal Transduction and Targeted Therapy, 2023. 8(1): 267.
Lau, V., L. Ramer, and M. Tremblay, An Aging, Pathology Burden, and Glial Senescence Build-Up Hypothesis for Late Onset Alzheimer’s Disease. Nature Communications, 2023. 14(1): 1670.
Monroe, K.M., et al., Therapeutic targeting of neuroimmune mechanisms in neurodegeneration. Nature Reviews Drug Discovery. 2026 Feb 16.
110.
Jo, D., et al., A New Paradigm in Sarcopenia: Cognitive Impairment Caused by Imbalanced Myokine Secretion and Vascular Dysfunction. Biomedicine & Pharmacotherapy, 2022. 147: 112636.
Kim, J., et al., Sarcopenia Is a Predictor for Alzheimer’s Continuum and Related Clinical Outcomes. Scientific Reports, 2024. 14(1): 21074.
Semba, R.D., et al., Motoric Cognitive Risk Syndrome: Integration of Two Early Harbingers of Dementia in Older Adults. Ageing Research Reviews, 2020. 58: 101022.
111.
McElhaney, J.E., et al., The Immune Response to Influenza in Older Humans: Beyond Immune Senescence. Immunity & Ageing, 2020. 17(1): 10.
Iwai-Saito, K., et al., Frailty Is Associated with Susceptibility and Severity of Pneumonia in Older Adults (A JAGES Multilevel Cross-Sectional Study). Scientific Reports, 2021. 11(1): 7966.
112.
Florence, G.E., T. Oosthuyse, and A.N. Bosch, Skeletal Site-Specific Effects of Jump Training on Bone Mineral Density in Adults: A Systematic Review and Meta-Analysis. Journal of Sports Sciences, 2023. 41(23): pp. 2063–76.
de Villarreal, E.S., B. Requena, and R.U. Newton, Does Plyometric Training Improve Strength Performance? A Meta-Analysis. Journal of Science and Medicine in Sport, 2010. 13(5): pp. 513–22.
Kons, R.L., et al., Effects of Plyometric Training on Physical Performance: An Umbrella Review. Sports Medicine—Open, 2023. 9(1): 4.
113.
Correa, C.S., et al., 3 Different Types of Strength Training in Older Women. International Journal of Sports Medicine, 2012. 33(12): pp. 962–69.
114.
Allison, S.J., K. Brooke-Wavell, and J. Folland, High and Odd Impact Exercise Training Improved Physical Function and Fall Risk Factors in Community-Dwelling Older Men. Journal of Musculoskeletal & Neuronal Interactions, 2018. 18(1): pp. 100–107.
115.
Manini, T.M. and B.C. Clark, Blood Flow Restricted Exercise and Skeletal Muscle Health. Exercise and Sport Sciences Reviews, 2009. 37(2).
116.
Hughes, L., et al., Blood Flow Restriction Training in Clinical Musculoskeletal Rehabilitation: A Systematic Review and Meta-Analysis. British Journal of Sports Medicine, 2017. 51(13): pp. 1003–11.
117.
Kambic, T., et al., Is Blood Flow Restriction Resistance Training the Missing Piece in Cardiac Rehabilitation of Frail Patients? European Journal of Preventive Cardiology, 2022. 30(2): pp. 117–22.
Patterson, S.D., et al., Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety. Frontiers in Physiology, 2019. 10: 533.
118.
Lim, Z.X. and J. Goh, Effects of Blood Flow Restriction (BFR) with Resistance Exercise on Musculoskeletal Health in Older Adults: A Narrative Review. European Review of Aging and Physical Activity, 2022. 19(1): 15.
Conceição, M.S. and C. Ugrinowitsch, Exercise with Blood Flow Restriction: An Effective Alternative for the Non-Pharmaceutical Treatment for Muscle Wasting. Journal of Cachexia, Sarcopenia and Muscle, 2019. 10(2): pp. 257–62.
Liu, Y., et al., Systematic Review and Meta-Analysis of the Effects of Blood Flow Restriction Training on Bone Health in Older Adults. Scientific Reports, 2025. 15(1): 12800.
Hughes et al., Blood Flow Restriction Training in Clinical Musculoskeletal Rehabilitation: A Systematic Review and Meta-Analysis. British Journal of Sports Medicine, 2017. 51(13): pp. 1003–11.
119.
Argyropoulou, D., et al., The Effects of Dietary Protein on Physical Performance and Body Composition in Middle Age and Older People Having Type II Diabetes Mellitus: A Randomized Pilot Study. European Journal of Nutrition, 2025. 64(1): 63.
120.
Bird, J.K., et al., The Effect of Long Chain Omega-3 Polyunsaturated Fatty Acids on Muscle Mass and Function in Sarcopenia: A Scoping Systematic Review and Meta-Analysis. Clinical Nutrition ESPEN, 2021. 46: pp. 73–86.
Dupont, J., et al., The Role of Omega-3 in the Prevention and Treatment of Sarcopenia. Aging Clinical and Experimental Research, 2019. 31(6): pp. 825–36.
121.
Widajanti, N., et al., The Effect of Vitamin D Supplementation to Parameter of Sarcopenia in Elderly People: a Systematic Review and Meta-Analysis. Canadian Geriatrics Journal, 2024. 27(1): pp. 63–75.
122.
Xie, C., et al., Effects of Vitamin K Supplementation on Bone Mineral Density at Different Sites and Bone Metabolism in the Middle-Aged and Elderly Population. Bone Joint Research, 2024. 13(12): pp. 750–63.
Ma, M., et al., Efficacy of Vitamin K2 in the Prevention and Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Public Health, 2022. 10: 979649.
Booth, S.L., et al., Association of Vitamin K with Cognitive Decline and Neuropathology in Community-Dwelling Older Persons. Alzheimers & Dementia. 2022 Apr 20;8(1):e12255.
123.
Groenendijk, I., et al., Impact of Magnesium on Bone Health in Older Adults: A Systematic Review and Meta-Analysis. Bone, 2022. 154: 116233.
124.
Cunningham, A.L., The Herpes Zoster Subunit Vaccine. Expert Opinion on Biological Therapy, 2016. 16(2): pp. 265–71.
125.
Thomas, S.L. and A.J. Hall, What Does Epidemiology Tell Us About Risk Factors for Herpes Zoster? The Lancet Infectious Diseases, 2004. 4(1): pp. 26–33.
126.
Eyting, M., et al., A Natural Experiment on the Effect of Herpes Zoster Vaccination on Dementia. Nature, 2025. 641(8062): pp. 438–46.
Xie, M., et al., The effect of shingles vaccination at different stages of the dementia disease course. Cell. 2025 Dec 11;188(25):7049-7064.e20.
127.
Pomirchy, M., et al., Herpes Zoster Vaccination and Dementia Occurrence. JAMA, 2025 Jun 17;333(23):2083-2092.
128.
Wainberg, M., et al., The Viral Hypothesis: How Herpes Viruses May Contribute to Alzheimer’s Disease. Molecular Psychiatry, 2021. 26(10): pp. 5476–80.
129.
Zhao, H., et al., Prospective cohort study evaluating the association between influenza vaccination and neurodegenerative diseases. npj Vaccines, 2024. 2;9(1):51.
Scherrer, J.F., et al., Lower Risk for Dementia Following Adult Tetanus, Diphtheria, and Pertussis (Tdap) Vaccination. The Journals of Gerontology: Series A, 2021. 13;76(8):1436-1443.
Taquet, M., et al., Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections. npj Vaccines, 2025. 10:130.
Polisky, V., et al., Varicella-zoster virus reactivation and the risk of dementia. Nature Medicine. 2025 Dec;31(12):4172-4179.
Pomirchy, M., et al., Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments. The Lancet Neurology, 2026. 25, 2, pp. 170 – 180.
130.
Risnes, K., et al., Mortality Among Young Adults Born Preterm and Early Term in 4 Nordic Nations. JAMA Network Open, 2021. 4(1): pp. e2032779–e2032779.
Crump, C., J. Sundquist, and K. Sundquist, Stroke Risks in Adult Survivors of Preterm Birth: National Cohort and Cosibling Study. Stroke, 2021. 52(8): pp. 2609–17.
Mosing, M.A., et al., Associations Between Birth Characteristics and Age-Related Cognitive Impairment and Dementia: A Registry-Based Cohort Study. PLOS Medicine, 2018. 15(7): e1002609.
131.
Antony, K.M., et al., Population-Based Estimation of the Preterm Birth Rate in Lilongwe, Malawi: Making Every Birth Count. AJP Reports, 2020. 10(1): pp. e78–e86.
132.
Aagaard, K., et al., The Placenta Harbors a Unique Microbiome. Science Translational Medicine, 2014. 6(237): 237ra65.
133.
Söderling, E. and K. Pienihäkkinen, Effects of Xylitol Chewing Gum and Candies on the Accumulation of Dental Plaque: A Systematic Review. Clinical Oral Investigations, 2022. 26(1): pp. 119–29.
Al-Humaid, J.A. and M. Bamashmous, Meta-Analysis on the Effectiveness of Xylitol in Caries Prevention. Journal of the International Society of Preventitive & Community Dentistry, 2022. 12(2): pp. 133–38.
134.
Valentine, G.C., et al., A Cluster Randomized Trial of Xylitol Chewing Gum for Prevention of Preterm Birth: The PPaX Trial. Med, 2025. 6(4).
135.
Kozarov, E.V., et al., Human Atherosclerotic Plaque Contains Viable Invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arteriosclerosis, Thrombosis, and Vascular Biology, 2005. 25(3): pp. e17–e18.
136.
Arbildo-Vega, H.I., et al., Periodontal Disease and Cardiovascular Disease: Umbrella Review. BMC Oral Health, 2024. 24(1): 1308.
Karhunen, P.J., et al., Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic Plaques. Journal of the American Heart Association. 2025 Aug 19;14(16):e041521.
137.
Dominy, S.S., et al., Porphyromonas gingivalis in Alzheimer’s Disease Brains: Evidence for Disease Causation and Treatment with Small-Molecule Inhibitors. Science Advances, 2019. 5(1): eaau3333.
138.
Soscia, S.J., et al., The Alzheimer’s Disease-Associated Amyloid Beta-Protein Is an Antimicrobial Peptide. PLoS One, 2010. 5(3): e9505.
139.
Asher, S., et al., Periodontal Health, Cognitive Decline, and Dementia: A Systematic Review and Meta-Analysis of Longitudinal Studies. Journal of the American Geriatrics Society, 2022. 70(9): pp. 2695–709.
Guo, H., et al., The Effect of Periodontitis on Dementia and Cognitive Impairment: A Meta-Analysis. International Journal of Environmental Research and Public Health, 2021. 18(13): 6823.
Lin, C.S., et al., An Umbrella Review on the Association Between Factors of Oral Health and Cognitive Dysfunction. Ageing Research Reviews. 2024 Jan;93:102128.
Choi, M., et al., Association of Oral Health and Chewing Ability with Cognitive Impairment and Dementia in Older Adults: Longitudinal Findings From a National Panel Study. Archives of Gerontology and Geriatriatrics. 2025 Nov;138:105970.
Rubinstein, T., et al., Periodontitis and brain magnetic resonance imaging markers of Alzheimer's disease and cognitive aging. Alzheimers & Dementia, 2024. 20(3):2191-2208.
Qi, X., et al., Association of Gum Treatment with Cognitive Decline and Dementia Risk among Older Adults with Periodontal Symptoms: A 12-Year Prospective Cohort Study. Neuroepidemiology, 2025. 59(4):313-322.
Meyer J., et al., Periodontal Disease Independently Associated With White Matter Hyperintensity Volume: A Measure of Cerebral Small Vessel Disease. Neurology, 2025. 1 (4) e000037.
140.
Zheng, D.X., et al., Periodontal Disease and Emotional Disorders: A Meta-Analysis. Journal of Clinical Periodontology, 2021. 48(2): pp. 180–204.
Erdrich, S., et al., An Association Between Poor Oral Health, Oral Microbiota, and Pain Identified in New Zealand Women with Central Sensitisation Disorders: A Prospective Clinical Study. Frontiers in Pain Research, 2025. 6:1577193.
141.
Beydoun, M.A., et al., Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer’s Disease Dementia in a Large National Survey. Journal of Alzheimer’s Disease, 2020. 75(1): pp. 157–72.
142.
Wu, Y., et al., Xylitol-Containing Chewing Gum Reduces Cariogenic and Periodontopathic Bacteria in Dental Plaque—Microbiome Investigation. Frontiers in Nutrition, 2022. 9: 882636.
Luo, S., et al., How Probiotics, Prebiotics, Synbiotics, and Postbiotics Prevent Dental Caries: An Oral Microbiota Perspective. npj Biofilms and Microbiomes, 2024. 10(1): 14.
143.
Morais, L.H., H.L. Schreiber, and Mazmanian, S.K., The Gut Microbiota–Brain Axis in Behaviour and Brain Disorders. Nature Reviews, Microbiology, 2021. 19(4): pp. 241–55.
Loh, J.S., et al., Microbiota–Gut–Brain Axis and Its Therapeutic Applications in Neurodegenerative Diseases. Signal Transduction and Targeted Therapy, 2024. 9(1): 37.
Cryan, J.F., et al., The Microbiota-Gut-Brain Axis. Physiolical Reviews. 2019 Oct 1;99(4):1877-2013.
Schneider, E., et al., Feeding gut microbes to nourish the brain: unravelling the diet-microbiota-gut-brain axis. Nature Metabolism. 2024 Aug;6(8):1454-1478.
144.
Sholl, J., L.J. Mailing, and T.R. Wood, Reframing Nutritional Microbiota Studies to Reflect an Inherent Metabolic Flexibility of the Human Gut: a Narrative Review Focusing on High-Fat Diets. mBio, 2021. 12(2).
145.
Lee, J.Y., et al., The Human Gut Microbiome in Health and Disease: Time for New Chapter? Infection and Immunity, 2024. 92(11): e0030224.
146.
Liang, X., et al., Gut Microbiome, Cognitive Function and Brain Structure: A Multi-Omics Integration Analysis. Translational Neurodegeneration, 2022. 11(1): 49.
Meyer, K., et al., Association of the Gut Microbiota with Cognitive Function in Midlife. JAMA Network Open, 2022. 5(2): e2143941.
147.
Clemente, J.C., et al., The Impact of the Gut Microbiota on Human Health: An Integrative View. Cell, 2012. 148(6): pp. 1258–70.
Gilbert, J.A., et al., Current Understanding of the Human Microbiome. Nature Medicine, 2018. 24(4): pp. 392–400.
148.
Askarova, S., et al., The Links Between the Gut Microbiome, Aging, Modern Lifestyle and Alzheimer’s Disease. Frontiers in Cellular and Infection Microbiology, 2020. 10: 104.
Parizadeh, M. and M. Arrieta, The Global Human Gut Microbiome: Genes, Lifestyles, and Diet. Trends in Molecular Medicine, 2023. 29(10): pp. 789–801.
Lee et al., The Human Gut Microbiome in Health and Disease: Time for New Chapter? Infection and Immunity, 2024. 92(11): e0030224.
149.
Ross, F.C., et al., The Interplay Between Diet and the Gut Microbiome: Implications for Health and Disease. Nature Reviews, Microbiology, 2024. 22(11): pp. 671–86.
Madison, A. and J.K. Kiecolt-Glaser, Stress, Depression, Diet, and the Gut Microbiota: Human-Bacteria Interactions at the Core of Psychoneuroimmunology and Nutrition. Current Opinions in Behavioral Sciences, 2019. 28: pp. 105–10.
Han, M., S. Yuan, and J. Zhang, The Interplay Between Sleep and Gut Microbiota. Brain Research Bulletin, 2022. 180: pp. 131–46.
Mailing, L.J., et al., Exercise and the Gut Microbiome: A Review of the Evidence, Potential Mechanisms, and Implications for Human Health. Exercise and Sport Sciences Review, 2019. 47(2): pp. 75–85.
Grosicki, G.J., et al., Gut Check: Unveiling the Influence of Acute Exercise on the Gut Microbiota. Experimental Physiology, 2023. 108(12): pp. 1466–80.
Dow, E., M.I. Hernandez, and C.S. Johnston, Eight Weeks of Resistance Exercise Improves Mood State and Intestinal Permeability in Healthy Adults: A Randomized Controlled Trial. Physiological Reports, 2025. 13(3): e70219.
Marwaha, K., et al., Exploring the Complex Relationship Between Psychosocial Stress and the Gut Microbiome: Implications for Inflammation and Immune Modulation. Journal of Applied Physiology (1985), 2025. 138(2): pp. 518–35.
150.
Bermingham, K.M., et al., Effects of a personalized Nutrition Program on Cardiometabolic Health: A Randomized Controlled Trial. Nature Medicine, 2024. 30(7): pp. 1888–97.
151.
Popp, C.J., et al., Effect of a Personalized Diet to Reduce Postprandial Glycemic Response vs a Low-fat Diet on Weight Loss in Adults with Abnormal Glucose Metabolism and Obesity: A Randomized Clinical Trial. JAMA Network Open, 2022. 5(9): e2233760.
152.
Wastyk, H.C., et al., Gut-Microbiota-Targeted Diets Modulate Human Immune Status. Cell, 2021. 184(16): pp. 4137–53.e14.
153.
Veronese, N., et al., The Impact of Dietary Fiber Consumption on Human Health: An Umbrella Review of Evidence from 17,155,277 Individuals. Clinical Nutrition. 2025 Aug;51:325-333.
Sanz, Y., et al., The Gut Microbiome Connects Nutrition and Human Health. Nature Reviews Gastroenterology and Hepatology. 2025 Aug;22(8):534-555.
Saghafian, F., et al., Dietary Fiber Intake, Depression, and Anxiety: a Systematic Review and Meta-Analysis of Epidemiologic Studies. Nutritional Neuroscience. 2023 Feb;26(2):108-126.
154.
Abolhasani, E., et al., Air Pollution and Incidence of Dementia: A Systematic Review and Meta-Analysis. Neurology, 2023. 100(2): pp. e242–e254.
Elser, H., et al., Wildfire Smoke Exposure and Incident Dementia. JAMA Neurology, 2025. 82(1): pp. 40–48; Peters, R., et al., Air Pollution and Dementia: A Systematic Review. Journal of Alzheimer’s Disease, 2019. 70(s1): pp. S145–s163.
Kim, B., et al., Ambient Air Pollution and the Severity of Alzheimer Disease Neuropathology. JAMA Neurology. 2025 Nov 1;82(11):1153-1161.
Zhang, X., et al., Lewy body dementia promotion by air pollutants. Science. 2025 Sep 4;389(6764):eadu4132.
Deng, Y., et al., The role of comorbidities in the associations between air pollution and Alzheimer's disease: A national cohort study in the American Medicare population. PLoS Medicine. 2026 Feb 17;23(2):e1004912.
155.
Ritchie, H. and M. Roser, Air Pollution: Our Overview of Indoor and Outdoor Air Pollution. Our World in Data, October 2017. Available↗
156.
Thomson, E.M., Air Pollution, Stress, and Allostatic Load: Linking Systemic and Central Nervous System Impacts. Journal of Alzheimer’s Disease, 2019. 69(3): pp. 597–614.
Yakovenko, N., et al., Human Exposure to PM10 Microplastics in Indoor Air. PLoS One. 2025 Jul 30;20(7):e0328011.
157.
Indoor Air Quality: What Are the Trends in Indoor Air Quality and Their Effects on Human Health? U.S. Environmental Protection Agency, 2024. Available↗
158.
Brugge, D., e al., Effect of HEPA Filtration Air Purifiers on Blood Pressure: A Pragmatic Randomized Crossover Trial. Journal of the American College of Cardiology. 2025 Aug 26;86(8):577-589.
159.
Chen, C., et al., B Vitamin Intakes Modify the Association Between Particulate Air Pollutants and Incidence of All-Cause Dementia: Findings from the Women’s Health Initiative Memory Study. Alzheimer’s & Dementia, 2022. 18(11): pp. 2188–98.
160.
Lee, H., et al., Childhood Lead Exposure Is Associated with Lower Cognitive Functioning at Older Ages. Science Advances, 2022. 8(45): eabn5164.
Hickman, R.C., et al., Prenatal and Early Postnatal Lead Exposure and Later Adulthood Cognitive Function in the St. Louis Baby Tooth-Later Life Health Study. Neurology. 2026 Mar 24;106(6):e214616.
Basic Information About Lead in Drinking Water. 2025; Cohen, L. EPA Finds More Than 9 Million Lead Pipes Supplying Drinking Water Throughout the U.S. 2023.
161.
Per- and Polyfluoroalkyl Substances (PFAS). U.S. Environmental Protection Agency, 2025. Available↗
Delcourt, N., et al., First Observations of a Potential Association Between Accumulation of Per- and Polyfluoroalkyl Substances in the Central Nervous System and Markers of Alzheimer’s Disease. The Journals of Gerontology: Series A, Biological Sciences and Medical Sciences, 2024. 79(3).
Suzuki, M., et al., Number of Carbons Is a Critical Parameter for Accumulation of Per- and Polyfluoroalkyl Substances in the Human Brain. Environmental Science & Technology, 2025. 59(7): pp. 3366–75.
Midya, V., et al., Exposure to Per- and Poly-Fluoroalkyl Substances in Association to Later Occurrence of Type 2 Diabetes and Metabolic Pathway Dysregulation in a Multiethnic US Population. EBioMedicine. 2025 Aug;118:105838.
Luo, Y., et al., Raman Imaging for the Identification of Teflon Microplastics and Nanoplastics Released from Non-Stick Cookware. Science of the Total Environment. 2022 Dec 10;851(Pt 2):158293.
162.
Marfella, R., et al., Microplastics and Nanoplastics in Atheromas and Cardiovascular Events. The New England Journal of Medicine, 2024. 390(10): pp. 900–910.
Nihart, A.J., et al., Bioaccumulation of Microplastics in Decedent Human Brains. Nature Medicine, 2025. 31(4): pp. 1114–19.
163.
Nihart et al., Bioaccumulation of Microplastics in Decedent Human Brains. Nature Medicine, 2025. 31(4): pp. 1114–19.
164.
Pletz, M., Ingested Microplastics: Do Humans Eat One Credit Card per week? Journal of Hazardous Materials Letters, 2022. 3: 100071.
Carrington, D., ‘A bombshell’: doubt cast on discovery of microplastics throughout human body. The Guardian, Jan 13 2026. Available↗
165.
Zhang, J., et al., Bisphenol A exposure and Neurodevelopmental Disorders and Problems in Children Under 12 Years of Age: A Systematic Review and Meta-Analysis. Journal of Hazardous Materials, 2025. 490: 137731.
Hyman, S., et al., Phthalate Exposure from Plastics and Cardiovascular Disease: Global Estimates of Attributable Mortality and Years Life Lost. eBioMedicine, 2025. 117.
166.
Prata, J. C., Microplastics and Human Health: Integrating Pharmacokinetics. Critical Reviews in Environmental Science and Technology, 2023. 53(16), 1489–1511.
Zhang, J., et al., Exploring the Potential Protective Role of Anthocyanins in Mitigating Micro/Nanoplastic-Induced Reproductive Toxicity: A Steroid Receptor Perspective. Journal of Pharmceutical Analysis, 2025. 15(2): 101148.
167.
Schlezinger, J.J., et al., An Oat Fiber Intervention for Reducing PFAS Body Burden: A Pilot Study in Male C57Bl/6 J Mice. Toxicology and Applied Pharmacology, 2025. 495: 117188.
Ho, H.V., et al., The Effect of Oat Β-Glucan on LDL-Cholesterol, Non-HDL-Cholesterol and Apob for CVD Risk Reduction: A Systematic Review and Meta-Analysis of Randomised-Controlled Trials. British Journal of Nutrition, 2016. 116(8): pp. 1369–82.
Wang, H., et al., Fighting Microplastics: The Role of Dietary Fibers in Protecting Health. Food Frontiers, 2024. 5, 1984–1998.
168.
Mielke, M.M., et al., Consideration of Sex and Gender in Alzheimer’s Disease and Related Disorders from a Global Perspective. Alzheimer’s & Dementia, 2022. 18(12): pp. 2707–24.
169.
Huang, L., et al., Association of Occupational Factors and Dementia or Cognitive Impairment: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease, 2020. 78(1): pp. 217–27.
Mielke et al., Consideration of Sex and Gender in Alzheimer’s Disease and Related Disorders from a Global Perspective. Alzheimer’s & Dementia, 2022. 18(12): pp. 2707–24.
Zugman, A., et al., Country-level gender inequality is associated with structural differences in the brains of women and men. Proceedings of the National Academy of Sciences. 2023 May 16;120(20):e2218782120.
170.
Women in the Labor Force: A Databook. U.S. Bureau of Labor Statistics, 2017. Available↗
171.
Gribbin, K., K.W. Schaie, and I.A. Parham, Complexity of Life Style and Maintenance of Intellectual Abilities. Journal of Social Issues, 1980. 36(2): pp. 47–61.
172.
Kaiser, C., et al., Two Paradoxes in Women’s Well-Being. Science Advances, 2025. 11(10): eadt1646.
173.
Lambrou, N.H., et al., Subjective Cognitive Decline Associated with Discrimination in Medical Settings Among Transgender and Nonbinary Older Adults. International Journal of Environmental Research and Public Health, 2022. 19(15).
Hsieh, N., H. Liu, and Z. Zhang, Perceived Discrimination and Incident Dementia Among Older Adults in the United States: The Buffering Role of Social Relationships. The Journals of Gerontology: Series B, Psychological Sciences and Social Sciences, 2024. 79(6).
Bancks, M.P., et al., Self-Reported Experiences of Discrimination and Incident Dementia. Alzheimer’s & Dementia, 2023. 19(7): pp. 3119–28.
Avila-Rieger, J.F., et al., Early Life Exposure to Structural Sexism and Late-Life Memory Trajectories Among Black and White Women and Men in the United States. Alzheimer’s & Dementia, 2025. 21(2): e14410.
Romanelli, R.J., et al., Cognitive Impairment in Sexual and Gender Minority Groups: A Scoping Review of the Literature. LGBT Health, 2024. 11(3): pp. 178–92.
174.
Fang, M., et al., Lifetime risk and Projected Burden of Dementia. Nature Medicine, 2025. 31(3): pp. 772–76.
175.
Mukadam, N., et al., South Asian, Black and White ethnicity and the Effect of Potentially Modifiable Risk Factors for Dementia: A Study in English Electronic Health Records. PLoS One, 2023. 18(10): e0289893.
176.
Desai, P., et al., The Social Vulnerability Index and Incidence of Alzheimer Disease in a Population-Based Sample of Older Adults. Neurology, 2025. 104(8): e213464.
177.
Xu, M., X. Yin, and Y. Gong, Lifestyle Factors in the Association of Shift Work and Depression and Anxiety. JAMA Netw Open, 2023. 6(8): e2328798.
Lee, K.W., et al., Shift Work Is Significantly and Positively Associated with Dementia: A Meta-Analysis Study. Frontiers in Public Health, 2023. 11: 998464.
Wu, Q.J., et al., Shift Work and Health Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses of Epidemiological Studies. Journal of Clinical Sleep Medicine, 2022. 18(2): pp. 653–62.
178.
Kivimäki, M., et al., Social Disadvantage Accelerates Aging. Nature Medicine, 2025. 31(5): pp. 1635–43.
Klee, M., et al., Socioeconomic Deprivation, Genetic Risk, and Incident Dementia. American Journal of Preventive Medicine, 2023. 64(5): pp. 621–30.
Stulberg, E.L., et al., Income, Race-Ethnicity, and Dementia Risk Factors in the United States. Neurology. 2025 Dec 9;105(11):e214402.
Hendriks, S., et al., Risk Factors for Young-Onset Dementia in the UK Biobank. JAMA Neurology, 2024. 81(2): pp. 134–42.
Gogniat, M.A., et al., Cross-Sectional and Longitudinal Associations of Neighborhood Disadvantage With Fluid
Biomarkers of Neuroinflammation and Neurodegeneration. Neurology. 2025 Jul 22;105(2):e213770.
Migeot, J., et al., Social exposome and brain health outcomes of dementia across Latin America. Nature Communications. 2025 Sep 11;16(1):8196.
179.
Dai, X., J. Yan, and X. Bi, Weekly Fluctuations in Subjective and Objective Measures of Internal Training Load and Their Relationships in Male Elite Rowers. Journal of Sports Science and Medicine, 2025. 24(2): pp. 269–76.
D’Alleva, M., et al., The Relationship Between Training Load and Acute Performance Decrements Following Different Types of Training Sessions in Well-Trained Runners. Intational Journal of Sports Physiology and Performance, 2025. 20(6): pp. 823–33.
Saw, A.E., L.C. Main, and B. Gastin, Monitoring the Athlete Training Response: Subjective Self-Reported Measures Trump Commonly Used Objective Measures: A Systematic Review. British Journal of Sports Medicine, 2016. 50(5): pp. 281–91.
180.
Weakley, J., S.L. Halson, and I. Mujika, Overtraining Syndrome Symptoms and Diagnosis in Athletes: Where Is the Research? A Systematic Review. International Journal of Sports Physiology and Performance, 2022. 17(5): pp. 675–81.
Kellmann, M., Preventing Overtraining in Athletes in High-Intensity Sports and Stress/Recovery Monitoring. Scandinavian Journal of Medicine & Science in Sports, 2010. 20(s2): pp. 95–102.
181.
Denno, P., et al., Defining Brain Fog Across Medical Conditions. Trends in Neurosciences, 2025. 48(5): pp. 330–48.
Jessen, F., et al., The Characterisation of Subjective Cognitive Decline. The Lancet Neurology, 2020. 19(3): pp. 271–78.
182.
Jessen et al., The Characterisation of Subjective Cognitive Decline. The Lancet Neurology, 2020. 19(3): pp. 271–78.
Denno, P., et al., Defining Brain Fog Across Medical Conditions. Trends in Neurosciences, 2025. 48(5): pp. 330–48.
Alim-Marvasti, A., et al., Subjective brain fog: a four-dimensional characterization in 25,796 participants. Frontiers in Human Neuroscience. 2024 Jun 6;18:1409250.
van der Feltz-Cornelis, C., et al., Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis. General Hospital Psychiatry. 2024 May-Jun;88:10-22.
Frisoni, G.B., et al., New landscape of the diagnosis of Alzheimer's disease. Lancet. 2025 Sep 27;406(10510):1389-1407.
Frisoni, G.B., et al., Alzheimer's disease outlook: controversies and future directions. Lancet. 2025 Sep 27;406(10510):1424-1442.
183.
Jessen et al., The Characterisation of Subjective Cognitive Decline. The Lancet Neurology, 2020. 19(3): pp. 271–78.